Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Vago

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Nature Medicine|March 27, 2019
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Blood|July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulationJenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.
The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Blood|October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AMLViktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2026
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell TransplantationKatharina Fleischhauer, Cristina Toffalori, Federica Cugnata, et al.
Blood|August 24, 2016
Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHDRaphael Carapito, Nicolas Jung, Marius Kwemou, et al.
Nature Medicine|April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine|February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Nature Medicine|March 27, 2019
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Blood|July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulationJenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.
The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Blood|October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AMLViktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2026
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell TransplantationKatharina Fleischhauer, Cristina Toffalori, Federica Cugnata, et al.
Blood|August 24, 2016
Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHDRaphael Carapito, Nicolas Jung, Marius Kwemou, et al.
Nature Medicine|April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine|February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Pageof 12